This adds to the sample-focused analysis of twenty-three cases amid latest 39 months, according to our methods of research in addition to re-do MDM2 profiling in another 35 patients across two studies and another cohort evaluating the outcome in cardiac sarcomas. The gene discussed is MDM2; the disease is heart sarcoma.